New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
07:59 EDTESRX, ZGNXZogenix price target lowered to $2.50 from $5 at Oppenheimer
Oppenheimer cut its price target on Zogenix (ZGNX) after coverage of the company's Zohydro painkiller was terminated by Express Scripts (ESRX). However, the firm thinks recent disappointing news about Zogenix is already reflected in the stock. Oppenheimer keeps an Outperform rating on the shares.
News For ZGNX;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
11:21 EDTESRXMorgan Stanley reports 5% passive stake in Express Scripts
Subscribe for More Information
June 25, 2015
05:48 EDTESRXStocks with implied volatility movement; SDS ESRX
Stocks with implied volatility movement; UltraShort S&P500 ProShares (SDS) 28, Express Scripts (ESRX) 27 according to iVolatility.
June 24, 2015
14:13 EDTESRXExpress Scripts July weekly volatility elevated as shares near record high
Subscribe for More Information
June 22, 2015
08:16 EDTESRXAnthem, Cigna deal would be negative for Catamaran, says Leerink
Subscribe for More Information
June 19, 2015
11:17 EDTESRXExpress Scripts calls active amid bid speculation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use